{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:32Z","timestamp":1792783652297,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["No. 82400217"],"award-info":[{"award-number":["No. 82400217"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["No. LBY24H080003"],"award-info":[{"award-number":["No. LBY24H080003"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Several recent studies have focused on human endogenous retroviruses (HERVs). HERVs entered the human genome millions of years ago and are associated with various diseases including cancer and immune regulation. Among these, the HERV-K family exhibits the highest transcriptional activity. However, little is known about the expression of HERVs in acute myeloid leukemia (AML) and their potential as biomarkers or therapeutic targets. This study primarily investigated the role of HERV-K102 in AML development and explored the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression profiles of HERV K102 in AML and normal samples were analyzed using The Cancer Genome Atlas (TCGA) database and AML cell lines. Knockout models were generated using CRISPR-Cas9-mediated deletion of the HERV-K102 envelope (K-Env). Cell viability and pyroptosis rates were measured using the MTT assay and flow cytometry, respectively. Transcriptome analysis was performed to identify differentially expressed genes and related pathways. Pyroptosis markers were detected using qRT-PCR and western blotting. The role of HERV-K102 in AML was validated using an inducible knockout xenograft tumor model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>HERV-K102 was aberrantly activated and highly expressed in AML cells. K-Env depletion inhibited AML cell proliferation and promoted apoptosis. Furthermore, K-Env knockout induced pyroptosis, as indicated by increased lactate dehydrogenase (LDH) release and enhanced cleavage of caspase-1 and gasdermin D (GSDMD). Transcriptomic and functional analyses demonstrated that this process is mediated by S100A9 upregulation and activation of the NOD-like receptor protein 3 (NLRP3) inflammasome pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that HERV-K102 Env may play an important role in AML pathogenesis and represents a novel diagnostic and therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s44313-026-00134-5","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:34:53Z","timestamp":1776130493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the HERV-K102 envelope elicits pyroptosis and represents a novel therapeutic strategy for acute myeloid leukemia"],"prefix":"10.1007","volume":"61","author":[{"given":"Lihong","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev.genom.7.080505.115700","volume":"7","author":"N Bannert","year":"2006","unstructured":"Bannert N, Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet. 2006;7:149\u201373. https:\/\/doi.org\/10.1146\/annurev.genom.7.080505.115700.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-4690-8-90","volume":"8","author":"RP Subramanian","year":"2011","unstructured":"Subramanian RP, Wildschutte JH, Russo C, Coffin JM. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 2011;8:90. https:\/\/doi.org\/10.1186\/1742-4690-8-90.","journal-title":"Retrovirology"},{"key":"134_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1101\/gr.5565706","volume":"16","author":"M Dewannieux","year":"2006","unstructured":"Dewannieux M, et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 2006;16:1548\u201356. https:\/\/doi.org\/10.1101\/gr.5565706.","journal-title":"Genome Res"},{"key":"134_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1099\/vir.0.83534-0","volume":"89","author":"K Boller","year":"2008","unstructured":"Boller K, et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol. 2008;89:567\u201372. https:\/\/doi.org\/10.1099\/vir.0.83534-0.","journal-title":"J Gen Virol"},{"key":"134_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ijc.29003","volume":"137","author":"RF Downey","year":"2015","unstructured":"Downey RF, et al. Human endogenous retrovirus K and cancer: innocent bystander or tumorigenic accomplice? Int J Cancer. 2015;137:1249\u201357. https:\/\/doi.org\/10.1002\/ijc.29003.","journal-title":"Int J Cancer"},{"key":"134_CR6","doi-asserted-by":"publisher","first-page":"e6711","DOI":"10.7717\/peerj.6711","volume":"7","author":"M Greenig","year":"2019","unstructured":"Greenig M. HERVs, immunity, and autoimmunity: understanding the connection. PeerJ. 2019;7:e6711. https:\/\/doi.org\/10.7717\/peerj.6711.","journal-title":"PeerJ"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"648629","DOI":"10.3389\/fnins.2021.648629","volume":"15","author":"C R\u00f6mer","year":"2021","unstructured":"R\u00f6mer C. Viruses and endogenous retroviruses as roots for neuroinflammation and neurodegenerative diseases. Front Neurosci. 2021;15:648629. https:\/\/doi.org\/10.3389\/fnins.2021.648629.","journal-title":"Front Neurosci"},{"key":"134_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cell.2022.12.017","volume":"186","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Resurrection of endogenous retroviruses during aging reinforces senescence. Cell. 2023;186:287-304.e226. https:\/\/doi.org\/10.1016\/j.cell.2022.12.017.","journal-title":"Cell"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc.2017.35","volume":"17","author":"KH Burns","year":"2017","unstructured":"Burns KH. Transposable elements in cancer. Nat Rev Cancer. 2017;17:415\u201324. https:\/\/doi.org\/10.1038\/nrc.2017.35.","journal-title":"Nat Rev Cancer"},{"key":"134_CR10","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1128\/jvi.00646-08","volume":"82","author":"R Contreras-Galindo","year":"2008","unstructured":"Contreras-Galindo R, et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 2008;82:9329\u201336. https:\/\/doi.org\/10.1128\/jvi.00646-08.","journal-title":"J Virol"},{"key":"134_CR11","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.Can-07-6838","volume":"68","author":"F Wang-Johanning","year":"2008","unstructured":"Wang-Johanning F, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008;68:5869\u201377. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-6838.","journal-title":"Cancer Res"},{"key":"134_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.22256","volume":"120","author":"F Wang-Johanning","year":"2007","unstructured":"Wang-Johanning F, et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer. 2007;120:81\u201390. https:\/\/doi.org\/10.1002\/ijc.22256.","journal-title":"Int J Cancer"},{"key":"134_CR13","doi-asserted-by":"publisher","first-page":"e76281","DOI":"10.1371\/journal.pone.0076281","volume":"8","author":"P Maliniemi","year":"2013","unstructured":"Maliniemi P, et al. Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma. PLoS ONE. 2013;8:e76281. https:\/\/doi.org\/10.1371\/journal.pone.0076281.","journal-title":"PLoS ONE"},{"key":"134_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/gcc.20751","volume":"49","author":"S Stengel","year":"2010","unstructured":"Stengel S, Fiebig U, Kurth R, Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer. 2010;49:401\u201311. https:\/\/doi.org\/10.1002\/gcc.20751.","journal-title":"Genes Chromosomes Cancer"},{"key":"134_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000345407","volume":"129","author":"D Januszkiewicz-Lewandowska","year":"2013","unstructured":"Januszkiewicz-Lewandowska D, et al. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells. Acta Haematol. 2013;129:232\u20137. https:\/\/doi.org\/10.1159\/000345407.","journal-title":"Acta Haematol"},{"key":"134_CR16","doi-asserted-by":"publisher","unstructured":"Curty G, et al. Human endogenous retrovirus K in cancer: A potential biomarker and immunotherapeutic target. Viruses. 2020;12. https:\/\/doi.org\/10.3390\/v12070726.","DOI":"10.3390\/v12070726"},{"key":"134_CR17","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"SK Hsu","year":"2021","unstructured":"Hsu SK, et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11:8813\u201335. https:\/\/doi.org\/10.7150\/thno.62521.","journal-title":"Theranostics"},{"key":"134_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19:971\u201392. https:\/\/doi.org\/10.1038\/s41423-022-00905-x.","journal-title":"Cell Mol Immunol"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, et al. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298. https:\/\/doi.org\/10.3389\/fimmu.2018.01298.","journal-title":"Front Immunol"},{"key":"134_CR20","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","volume":"128","author":"AA Basiorka","year":"2016","unstructured":"Basiorka AA, et al. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood. 2016;128:2960\u201375. https:\/\/doi.org\/10.1182\/blood-2016-07-730556.","journal-title":"Blood"},{"key":"134_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-025-00600-3","volume":"14","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, et al. EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromes. Exp Hematol Oncol. 2025;14:9. https:\/\/doi.org\/10.1186\/s40164-025-00600-3.","journal-title":"Exp Hematol Oncol"},{"key":"134_CR22","doi-asserted-by":"publisher","unstructured":"Li M, et al. HERV-K TM subunit elicits CD8(+) T cell anergy and tumor immune evasion via targeting CD3 coreceptor \u03b5 in AML and PDAC. Adv Sci (Weinh). 2026;e17432. https:\/\/doi.org\/10.1002\/advs.202417432.","DOI":"10.1002\/advs.202417432"},{"key":"134_CR23","doi-asserted-by":"publisher","unstructured":"Fu B, Ma H, Liu D. Functions and regulation of endogenous retrovirus elements during zygotic genome activation: Implications for improving somatic cell nuclear transfer efficiency. Biomolecules. 2021;11. https:\/\/doi.org\/10.3390\/biom11060829.","DOI":"10.3390\/biom11060829"},{"key":"134_CR24","doi-asserted-by":"publisher","unstructured":"Tokuyama M, et al. Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. J Exp Med. 2021;218. https:\/\/doi.org\/10.1084\/jem.20191766.","DOI":"10.1084\/jem.20191766"},{"key":"134_CR25","doi-asserted-by":"publisher","unstructured":"Laine A, et al. Expression of envelope protein encoded by endogenous retrovirus K102 in rheumatoid arthritis neutrophils. Microorganisms. 2023;11. https:\/\/doi.org\/10.3390\/microorganisms11051310.","DOI":"10.3390\/microorganisms11051310"},{"key":"134_CR26","doi-asserted-by":"publisher","first-page":"1533740","DOI":"10.3389\/fimmu.2024.1533740","volume":"15","author":"Q Gong","year":"2024","unstructured":"Gong Q, Xu R. Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer. Front Immunol. 2024;15:1533740. https:\/\/doi.org\/10.3389\/fimmu.2024.1533740.","journal-title":"Front Immunol"},{"key":"134_CR27","doi-asserted-by":"publisher","unstructured":"Ko EJ, et al. Human endogenous retrovirus (HERV)-K env gene knockout affects tumorigenic characteristics of nupr1 gene in DLD-1 colorectal cancer cells. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22083941.","DOI":"10.3390\/ijms22083941"},{"key":"134_CR28","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1158\/1078-0432.Ccr-17-0001","volume":"23","author":"M Li","year":"2017","unstructured":"Li M, et al. Downregulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clin Cancer Res. 2017;23:5892\u2013911. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-0001.","journal-title":"Clin Cancer Res"},{"key":"134_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, et al. Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42:1321\u201331. https:\/\/doi.org\/10.1080\/00365520701416709.","journal-title":"Scand J Gastroenterol"},{"key":"134_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109. https:\/\/doi.org\/10.1038\/nrc3893.","journal-title":"Nat Rev Cancer"},{"key":"134_CR31","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/ijc.29262","volume":"136","author":"S Funk","year":"2015","unstructured":"Funk S, et al. High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma. Int J Cancer. 2015;136:2037\u201346. https:\/\/doi.org\/10.1002\/ijc.29262.","journal-title":"Int J Cancer"},{"key":"134_CR32","doi-asserted-by":"publisher","unstructured":"Shin W, Mun S, Han K. Human endogenous retrovirus-K (HML-2)-related genetic variation: Human genome diversity and disease. Genes. 2023;14. https:\/\/doi.org\/10.3390\/genes14122150.","DOI":"10.3390\/genes14122150"},{"key":"134_CR33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/15384101.2018.1442623","volume":"17","author":"M Daskalakis","year":"2018","unstructured":"Daskalakis M, et al. Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors. Cell Cycle. 2018;17:811\u201322. https:\/\/doi.org\/10.1080\/15384101.2018.1442623.","journal-title":"Cell Cycle"},{"key":"134_CR34","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","volume":"69","author":"SO Vasudevan","year":"2023","unstructured":"Vasudevan SO, Behl B, Rathinam VA. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023;69:101781. https:\/\/doi.org\/10.1016\/j.smim.2023.101781.","journal-title":"Semin Immunol"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-026-00134-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:21:26Z","timestamp":1791354086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-026-00134-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s44313-026-00134-5","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23"}}